Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans
NCT ID: NCT01688154
Last Updated: 2013-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2013-02-28
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers
NCT06422741
The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension
NCT00979732
The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)
NCT00713167
Effect of Grape Seed Extract on Blood Pressure
NCT00869193
Effect of Acute Grape Seed Extract Supplementation on the Heart Rate Recovery in Young Individuals
NCT07137988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Product 1
35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)
35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)
Control product
2 empty capsules
2 empty capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)
2 empty capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signing the informed consent
Exclusion Criteria
* Smokers
* Regular medication
* Consumption of medication during the last week
* Following a weight-loss diet
* Vegetarians
* Abnormal glucose levels
* Diabetes
* Cardiovascular disease
* Gastrointestinal disease
* Anemia
* Nuts allergy
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Rovira i Virgili
OTHER
Hospital Universitari Sant Joan de Reus
OTHER
Technological Centre of Nutrition and Health, Spain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosa SolĂ , PhD
Role: PRINCIPAL_INVESTIGATOR
University Rovira i Virgili
Maria Cinta Bladé, PhD
Role: PRINCIPAL_INVESTIGATOR
University Rovira i Virgili
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CTNS
Reus, Tarragona, Spain
Technological Center of Nutrition and Health (CTNS)
Reus, Tarragona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
306724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.